CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Amethyst NSCLC trial: Phase 2, parallel-arm study of receptor tyrosine kinase (RTK) inhibitor, MGCD265, in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC) with activating genetic alterations in mesenchymal-epithelial transition factor ( MET
Author
Ashiq Masood
Balazs Halmos
+17Â more
Collin M. Blakely
Demiana Faltaos
Ebenezer A. Kio
Hamid R. Mirshahidi
Igor I. Rybkin
James Christensen
John J. Nemunaitis
Keith D. Eaton
Marshall T. Schreeder
Merrill Kingman Shum
Neelesh Sharma
Pasi A. Janne
Raul R. Mena
Richard C. Chao
Steven J. Saccaro
Vanessa Roberts Tassell
Yanis Boumber
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref